These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30743003)

  • 1. Ethylene carbodiimide-fixed donor splenocytes combined with cordycepin induce long-term protection to mice cardiac allografts.
    Xingqiang L; Fen N; Zhongpeng Y; Tiantian W; Lei Z; Jiali F; Junjie M; Guanghui L; Lu X; Yuhe G; Zheng C
    Transpl Immunol; 2019 Oct; 56():101196. PubMed ID: 30743003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethylene carbodiimide-fixed donor splenocytes combined with α-1 antitrypsin induce indefinite donor-specific protection to mice cardiac allografts.
    Lai X; Qiu L; Zhao Y; Yu S; Wang C; Zhang J; Ning F; Chen L; Chen G
    Transpl Int; 2017 Mar; 30(3):305-317. PubMed ID: 27957767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion of ethylene carbodiimide-fixed donor splenocytes prolongs survival of vascularized skin allografts.
    Ding J; Liu S; Zhang D; Song Y; Ma X; Yi C; Song B; Xiao B; Su Y; Guo S
    J Surg Res; 2018 Jan; 221():343-352. PubMed ID: 29229149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ECDI-fixed allogeneic splenocytes combined with α1-antitrypsin prolong survival of rat renal allografts.
    Chen G; Li J; Chen L; Lai X; Qiu J
    Int Immunopharmacol; 2015 May; 26(1):43-9. PubMed ID: 25749496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intragraft CD11b(+) IDO(+) cells mediate cardiac allograft tolerance by ECDI-fixed donor splenocyte infusions.
    Chen G; Kheradmand T; Bryant J; Wang S; Tasch J; Wang JJ; Zhang Z; Luo X
    Am J Transplant; 2012 Nov; 12(11):2920-9. PubMed ID: 22883222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethylenecarbodiimide-fixed donor splenocyte infusions differentially target direct and indirect pathways of allorecognition for induction of transplant tolerance.
    Kheradmand T; Wang S; Bryant J; Tasch JJ; Lerret N; Pothoven KL; Houlihan JL; Miller SD; Zhang ZJ; Luo X
    J Immunol; 2012 Jul; 189(2):804-12. PubMed ID: 22696445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of OX40/OX40L pathway combined with ethylene-carbodiimide-fixed donor splenocytes induces donor-specific allograft tolerance in presensitized recipients.
    Lai X; Yao Z; Ning F; Zhang L; Fang J; Li G; Xu L; Xiong Y; Liu L; Chen R; Ma J; Chen Z
    Ann Transl Med; 2020 Feb; 8(4):84. PubMed ID: 32175377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preemptive Tolerogenic Delivery of Donor Antigens for Permanent Allogeneic Islet Graft Protection.
    Wang S; Zhang X; Zhang L; Bryant J; Kheradmand T; Hering BJ; Miller SD; Luo X
    Cell Transplant; 2015; 24(6):1155-65. PubMed ID: 24759564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient B-cell depletion combined with apoptotic donor splenocytes induces xeno-specific T- and B-cell tolerance to islet xenografts.
    Wang S; Tasch J; Kheradmand T; Ulaszek J; Ely S; Zhang X; Hering BJ; Miller SD; Luo X
    Diabetes; 2013 Sep; 62(9):3143-50. PubMed ID: 23852699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preemptive donor apoptotic cell infusions induce IFN-γ-producing myeloid-derived suppressor cells for cardiac allograft protection.
    Bryant J; Lerret NM; Wang JJ; Kang HK; Tasch J; Zhang Z; Luo X
    J Immunol; 2014 Jun; 192(12):6092-101. PubMed ID: 24808363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ECDI-fixed donor splenocytes prolong skin allograft survival by promoting M2 macrophage polarization and inducing regulatory T cells.
    Zhou B; Zhang Y; Zhang D; Zhang Y; Xie J; Zhang X; Ding J; Su Y; Guo S; Zhuang R
    FASEB Bioadv; 2019 Nov; 1(11):706-718. PubMed ID: 32123816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
    Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R
    J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment of transfused donor splenocytes and allografts with mitomycin C attenuates acute rejection in heart transplantation in mice.
    Liu L; Wang F; Zheng Y; Yuan X; Wang D; Zeng W; He X; Wang C; Deng S
    Transplant Proc; 2014 May; 46(4):1169-74. PubMed ID: 24815153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous allograft tolerance in B7-deficient mice independent of preexisting endogenous CD4+CD25+ regulatory T-cells.
    Grazia TJ; Plenter RJ; Doan AN; Kelly BP; Weber SM; Kurche JS; Cushing SO; Gill RG; Pietra BA
    Transplantation; 2007 Jun; 83(11):1449-58. PubMed ID: 17565318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing PLG nanoparticle-peptide delivery platforms for transplantation tolerance using an allogeneic skin transplant model.
    Shah S; Daneshmandi S; Hughes KR; Yu S; Bedoya AM; Shea LD; Luo X
    Biomaterials; 2019 Jul; 210():70-82. PubMed ID: 31077862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
    Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
    J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term MyD88 inhibition ameliorates cardiac graft rejection and promotes donor-specific hyporesponsiveness of skin grafts in mice.
    He WT; Zhang LM; Li C; Li SY; Ding ZC; Fang ZM; Meng FY; Chen ZK; Zhou P
    Transpl Int; 2016 Aug; 29(8):941-52. PubMed ID: 27125343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.